Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3695473010 | Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3695475015 | Granisetron 129.167 microgram/hour prolonged-release transdermal patch | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has manufactured dose form | Prolonged-release transdermal patch (dose form) | true | Inferred relationship | Some | ||
| Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength numerator value | 129.167 | false | Inferred relationship | Some | 1 | |
| Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has concentration strength denominator unit | hour | true | Inferred relationship | Some | 1 | |
| Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has precise active ingredient | Granisetron (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has basis of strength substance (attribute) | Granisetron (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Is a | Granisetron-containing product in transdermal dose form | false | Inferred relationship | Some | ||
| Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Is a | Granisetron only product in transdermal dose form | true | Inferred relationship | Some | ||
| Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Plays role | Antiemetic therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR